Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pentoxifylline and Tocopherol for Mandibular Osteoradionecrosis
2014-004975-22Phase 3Completed
- Sponsor
- Vall d'Hebron University Hospital
- Start
- Jun 2015
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-arm trial of pentoxifylline and tocopherol in Mandibular osteoradionecrosis (ORN), sponsored by Vall d'Hebron University Hospital. Started Jun 2015; status: completed.
02
Drugs
pentoxifyllinetocopherol
03
Conditions
Mandibular osteoradionecrosis (ORN)
Beyond the preview
Go deeper on 2014-004975-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-004975-22.